• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    NeOnc Technologies Holdings, Inc. - Common Stock (NQ:NTHI)

    9.350 +0.400 (+4.47%)
    Streaming Delayed Price Updated: 11:15 AM EST, Jan 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about NeOnc Technologies Holdings, Inc. - Common Stock

    < Previous 1 2 Next >
    News headline image
    Stonegate Capital Partners Initiates Coverage on NeOnc Technologies Holdings, Inc. (NTHI)
    Dallas, Texas--(Newsfile Corp. - January 9, 2026) - NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI). Stonegate Capital Partners initiates their coverage... 
    Via Newsfile
    News headline image
    New to The Street Airs Tonight on Bloomberg Television - Show No. 712 Sponsored Programming Spotlighting Public and Private Market Innovators
    Via ACCESS Newswire
    News headline image
    New to The Street Show #710 Airs Tonight at 6:30 PM EST on Bloomberg Television
    Via ACCESS Newswire
    News headline image
    New to The Street Broadcasts Nationwide Tonight on Bloomberg Television Featuring NeOnc ($NTHI), Metaterra Holdings Inc., CISO Global ($CISO), and NRx Pharmaceuticals ($NRXP)
    Via ACCESS Newswire
    News headline image
    NeOnc Technologies Reports Updated Clinical Results
    Expanded Clinical Experience Demonstrates Additional Long-Term Survival and Radiographic Remission in Recurrent Grade III/IV IDH1-Mutant Astrocytoma Treated with Intranasal NEO100 
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies Holdings Reports Third Quarter 2025 Results and Provides Operational Update
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies Completes Enrollment in Pivotal NEO100 Phase2a Trial for IDH-1 mutant Recurrent High‑Grade Glioma and Expects Interim Data Readout in SixMonths (Q22026)
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies Reports Updated Clinical Results
    Results of Clinical Trials Provide Evidence Supporting Significant Radiographic Response and Potential Long-Term Survival in Recurrent Grade III/IV IDH1-Mutant Astrocytoma Treated with Intranasal... 
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies Appoints Amir Heshmatpour as Chief Executive Officer to Drive Next Phase of Clinical and Corporate Growth
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    His Highness Sheikh Nahyan bin Zayed Al Nahyan Assumes Executive Chairmanship of NeOnc Technologies' Subsidiary, NuroMENA, Pioneering UAE-US Partnership in Brain Cancer Treatment
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Meet the Companies - New to The Street's Accredited Investor Event Returns October 21-22 at Hudson Yards, NYC
    Via ACCESS Newswire
    News headline image
    NeOnc Technologies' Subsidiary, NuroMENA, Signs Master Services Agreement with M42’s IROS and Expands Board of Directors
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    New to The Street to Broadcast Tonight on Fox Business 10:30 PM PST Featuring NeOnc Technologies, FLOKI, XION, Sharps Technology, and Aeries Technology
    Via ACCESS Newswire
    News headline image
    NeOnc Technologies and Quazar Investment Set to Close $50 Million Strategic Partnership by October 23rd Following Final UAE Tax Approvals
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies Appoints Dr. David M. Ashley, Director of The Preston Robert Tisch Brain Tumor Center at Duke, to Scientific Advisory Board
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies Welcomes Dr. Alexandra M. Miller, Chief of Neuro-Oncology and Co-Director of the Brain and Spine Tumor Center at NYU Langone Health’s Perlmutter Cancer Center, to Its Scientific Advisory Board
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies Appoints Renowned Neuro-Oncologist Dr. Henry S. Friedman to Scientific Advisory Board
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    New to The Street to Broadcast Saturday, September 27th Featuring NeOnc Pharma $NTHI and Other Innovative Companies
    Via ACCESS Newswire
    News headline image
    NeOnc Technologies to Showcase Progress on Addressing Brain Cancer to 63 Million TV Households on “Health Uncensored with Dr. Drew” on the Lifetime Network on September 25, premiering nationwide at 8:00 a.m. ET/PT
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    New to The Street to Broadcast Episode 686 Tonight on Bloomberg Television at 6:30 PM EST
    Via ACCESS Newswire
    News headline image
    NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies Closes Strategic Acquisition of Advanced AI and 3D Bioprinting IP, Appointing World-Renowned Scientist Dr. Ishwar K. Puri to its Board
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies Holdings Reports Second Quarter 2025 Results and Provides Operational Update
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    New to The Street's Esteemed Client NeOnc Technologies Finalizes $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation
    Via ACCESS Newswire
    News headline image
    NeOnc Technologies Finalizes All Contingencies for $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies Awarded $2.5 Million in NIH STTR Grants to Advance NEO212 in Gliomas and Leukemia
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    NeOnc Technologies Featured on Yahoo Finance's Podcast Trader Talk: AI and Biotech Take on Brain Cancer
    From NeOnc Technologies Holdings, Inc.
    Via GlobeNewswire
    News headline image
    New to The Street Signs NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) to 12-Part National Broadcast Series Including T.V. Network Features, Earned Media, Commercials, and Iconic Outdoor Billboards
    Via ACCESS Newswire
    < Previous 1 2 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.